New Content
 | Publication from Nature Clinical Practice, "Will focal therapy become a standard of care for men with localized prostate cancer?" by H. Ahmed, D. Pendse, R. Illing, C. Allen, J. van der Meulen, and M. Emberton is located on the Publications section. |
| Sonablate® Brochure |
Events
Upcoming Events
Press Releases/News Stories
|
August 14, 2007 - Misonix Highlights Recent Duke University Study Revealing Significant New Cancer Treatment May Be Possible with HIFU Technology |
|
August 8, 2007 - High Intensity Focused Ultrasound (HIFU) now Available at Center in Argentina |
|
July 30, 2007 - New Software for High Intensity Focused Ultrasound (HIFU) Treatment Against Prostate Cancer |
|
June 22, 2007 - HIFU for Prostate Cancer in Niagra Falls |
|
June 6, 2007 - Major Milestones Announced for Sonablate 500 HIFU Treatment of Prostate Cancer at Annual American Urology Association Conference |
|
March 29, 2007 - Misonix Announces First SB500 HIFU Prostate Cancer Hemiablation Treatment Delivering Perfect Scores for Patient Continence and Potency |
|
March 26, 2007 - Misonix Announces First Global HIFU Prostate Cancer Treatment Clinical Registry |
|
March 22, 2007 - Misonix Announces First Successful HIFU Procedures for Human Kidney Cancer |
|
March 20, 2007 - Misonix Spotlights HIFU Medical Devices for Prostate and Kidney Cancer Treatment at European Association of Urology Conference 2007 |
|
March 6, 2007 - Misonix Enlists Partnermed to Distribute Market Leading Sonablate® 500 HIFU Prostate Cancer Treatment Device in Northern Europe |
|
February 16, 2007 - Misonix Enlists Experienced Sonablate® 500 Distributor Takai Hospital Supply to Market Leading HIFU Prostate Cancer Treatment Device in Turkey, Greece and Cyprus - First Sale Reported in Turkey |
The Sonablate® is an investigational device limited by Federal Law to investigational use in the United States.